facebook-page-view
Advertisement

Dr Lal PathLabs CEO on acquisition plans and declining PE interest in diagnostics

By Joseph Rai

  • 08 Apr 2019
Premium
Dr Lal PathLabs CEO on acquisition plans and declining PE interest in diagnostics
Om Manchanda

Dr Lal PathLabs Ltd, which became the first Indian diagnostics chain to list on the stock exchanges in 2015, has continued to grow organically. In an interaction with VCCircle, CEO Om Manchanda talks about the company’s efforts to strike an acquisition despite having refrained from making an inorganic push thus ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.
Advertisement
Advertisement